Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Enfermedades(3)
Bioquímica(1)
Economía(1)
Farmacología y terapéutica(1)
Fisiología humana(1)
Dyslipidemia: Genetics, lipoprotein lipase and hindiii polymorphism
ReviewAbstract: The direct link between lipid metabolism alterations and the increase of cardiovascular risk are welPalabras claves:Coronary artery disease, dyslipidemia, HindIII, Lipoprotein Lipase, polymorphismsAutores:Cano-Ponce C., Carem Prieto, D’Addosio R., Garicano C.M.D., Hoedebecke K., Martínez M.S., Martínez N.G., Nava T.N., Parra S.M., Pérez A., Rojas E.R., Rojas M.P., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Vicuña P.M.Fuentes:scopusLipid profile reference intervals in individuals from Maracaibo, Venezuela: An insight from the Maracaibo City Metabolic Syndrome prevalence study
ArticleAbstract: Objectives: Cardiovascular diseases are the main cause of death in adults worldwide. Dyslipidemias aPalabras claves:Cardiovascular disease, dyslipidemia, lipid profile, Reference intervalsAutores:Aguirre M.A., Añez-Ramos R., Angulo V., Arráiz N., Bello L.M., Carem Prieto, Fortul Y., González M.C., Linares S., Marcano R.P., Naguib A., Pacheco E., Ponce C.C., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Villalobos M.Fuentes:googlescopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopus